Biology Reference
In-Depth Information
[49] Stumpf AN, van der Meijden ED, van Bergen CA, Willemze R, Falkenburg JH, Griffioen
M. Identification of 4 new HLA-DR-restricted minor histocompatibility antigens as
hematopoietic targets in antitumor immunity. Blood 2009;114:3684-92.
[50] Bleakley M, Otterud BE, Richardt JL, Mollerup AD, Hudecek M, Nishida T, et al. Leuke-
mia-associated minor histocompatibility antigen discovery using T-cell clones isolated
by
in vitro
stimulation of naive CD8
+
T cells. Blood 2010;115:4923-33.
[51] Broen K, Levenga H, Vos J, van BK, Fredrix H, Greupink-Draaisma A, et al. A polymor-
phism in the splice donor site of ZNF419 results in the novel renal cell carcinoma-asso-
ciated minor histocompatibility antigen ZAPHIR. PLoS One 2011;6:e21699.
[52] Brickner AG, Warren III EH, Caldwell JA, Akatsuka Y, Golovina TN, Zarling AL, et al.
The immunogenicity of a new human minor histocompatibility antigen results from
differential antigen processing. J Exp Med 2001;193:195-206.
[53] Spierings E, Gras S, Reiser JB, Mommaas B, Almekinders M, Kester MG, et al. Steric
hindrance and fast dissociation explain the lack of immunogenicity of the minor histo-
compatibility HA-1Arg Null allele. J Immunol 2009;182:4809-16.
[54] Kawase T, Akatsuka Y, Torikai H, Morishima S, Oka A, Tsujimura A, et al. Alternative
splicing due to an intronic SNP in HMSD generates a novel minor histocompatibility
antigen. Blood 2007;110:1055-63.
[55] Pierce RA, Field ED, Mutis T, Golovina TN, Von Kap-Herr C, Wilke M, et al. The HA-2 mi-
nor histocompatibility antigen is derived from a diallelic gene encoding a novel human
class I myosin protein. J Immunol 2001;167:3223-30.
[56] Mutis T, Gillespie G, Schrama E, Falkenburg JH, Moss P, Goulmy E. Tetrameric HLA
class I-minor histocompatibility antigen peptide complexes demonstrate minor histo-
compatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-
host disease. Nat Med 1999;5:839-42.
[57] Marijt WA, Heemskerk MH, Kloosterboer FM, Goulmy E, Kester MG, van der Hoorn MA,
et al. Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-
specific T cells can induce complete remissions of relapsed leukemia. Proc Natl Acad
Sci USA 2003;100:2742-7.
[58] Kircher B, Wolf M, Stevanovic S, Rammensee HG, Grubeck-Loebenstein B, Gastl G, et al.
Hematopoietic lineage-restricted minor histocompatibility antigen HA-1 in graft-ver-
sus-leukemia activity after donor lymphocyte infusion. J Immunother 2004;27:156-60.
[59] Nishida T, Akatsuka Y, Morishima Y, Hamajima N, Tsujimura K, Kuzushima K, et al.
Clinical relevance of a newly identified HLA-A24-restricted minor histocompatibility
antigen epitope derived from BCL2A1, ACC-1, in patients receiving HLA genotypically
matched unrelated bone marrow transplant. Br J Haematol 2004;124:629-35.
[60] Takami A, Sugimori C, Feng X, Yachie A, Kondo Y, Nishimura R, et al. Expansion and
activation of minor histocompatibility antigen HY-specific T cells associated with graft-
versus-leukemia response. Bone Marrow Transplant 2004;34:703-9.
[61] Atkinson K, Farrell C, Chapman G, Downs K, Penny R, Biggs J. Female marrow donors
increase the risk of acute graft-versus-host disease: effect of donor age and parity
and analysis of cell subpopulations in the donor marrow inoculum. Br J Haematol
1986;63:231-9.
[62] Gratwohl A, Hermans J, Niederwieser D, Van BA, van Houwelingen HC, Apperley J.
Female donors influence transplant-related mortality and relapse incidence in male
recipients of sibling blood and marrow transplants. Hematol J 2001;2:363-70.
[63] Markiewicz M, Siekiera U, Dzierzak-Mietla M, Zielinska P, Kyrcz-Krzemien S. The
impact of H-Y mismatches on results of HLA-matched unrelated allogeneic hemato-
poietic stem cell transplantation. Transplant Proc 2010;42:3297-300.
[64] Randolph SS, Gooley TA, Warren EH, Appelbaum FR, Riddell SR. Female donors con-
tribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched,
related hematopoietic stem cell transplants. Blood 2004;103:347-52.
[65] Gahrton G, Iacobelli S, Apperley J, Bandini G, Bjorkstrand B, Blade J, et al. The impact
of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for
multiple myeloma: reduced relapse risk in female to male transplants. Bone Marrow
Transplant 2005;35:609-17.
[66] Goulmy E, Schipper R, Pool J, Blokland E, Falkenburg JH, Vossen J, et al. Mismatches of
minor histocompatibility antigens between HLA-identical donors and recipients and
the development of graft-versus-host disease after bone marrow transplantation. N
Engl J Med 1996;334:281-5.
[67] Tseng LH, Lin MT, Hansen JA, Gooley T, Pei J, Smith AG, et al. Correlation between
disparity for the minor histocompatibility antigen HA-1 and the development of acute
graft-versus-host disease after allogeneic marrow transplantation. Blood 1999;94:2911-4.
[68] Arostegui JI, Gallardo D, Rodriguez-Luaces M, Querol S, Madrigal JA, Garcia-Lopez J,
et al. Genomic typing of minor histocompatibility antigen HA-1 by reference strand
mediated conformation analysis (RSCA). Tissue Antigens 2000;56:69-76.
55
Search WWH ::
Custom Search